(Interestingly both groups did better then what I believe the normal NHS outcome is. But both groups did worse what we see on this forum, however, we have “self-selection” on our side.)
LCK = low carb, MCCR=low fat
LCK = low carb, MCCR=low fat
Diabetes medications
Participants in the LCK group reduced their use of some diabetes-related medications more than participants in the MCCR group. Of ten participants who reported taking sulfonylureas or dipeptidyl peptidase-4 inhibitors before the intervention, all six participants assigned to the LCK group discontinued these medications by 12 months post-baseline (at the request of the study physicians, based on the study protocol), compared with none of the four participants in the MCCR group (p = .005, Fischer’s exact test). Two participants in the MCCR group began taking these medications, whereas no participants in the LCK group did so. Of 22 participants who reported taking metformin before the intervention, 3/10 in the in the LCK group discontinued the medication, compared with 0/12 in the MCCR group (p = .08, Fisher’s exact test). In addition, in the LCK group 1 person increased their dose of metformin and in the MCCR group 2 people decreased their metformin, with none of these changes being significantly different between groups (p > .3).
see https://www.nature.com/articles/s41387-017-0006-9Participants in the LCK group reduced their use of some diabetes-related medications more than participants in the MCCR group. Of ten participants who reported taking sulfonylureas or dipeptidyl peptidase-4 inhibitors before the intervention, all six participants assigned to the LCK group discontinued these medications by 12 months post-baseline (at the request of the study physicians, based on the study protocol), compared with none of the four participants in the MCCR group (p = .005, Fischer’s exact test). Two participants in the MCCR group began taking these medications, whereas no participants in the LCK group did so. Of 22 participants who reported taking metformin before the intervention, 3/10 in the in the LCK group discontinued the medication, compared with 0/12 in the MCCR group (p = .08, Fisher’s exact test). In addition, in the LCK group 1 person increased their dose of metformin and in the MCCR group 2 people decreased their metformin, with none of these changes being significantly different between groups (p > .3).